Huperzina A

Article

Huperzine A for the treatment of cognitive, mood, and functional deficits after moderate and severe TBI (HUP-TBI): results of a Phase II randomized controlled pilot study: implications for understanding the placebo effect.

Autor/s:

Zafonte RD, Fregni F, Bergin MJG, Goldstein R, Boudreau N, Monge I, Luz M, Frazier J, Giacino JT.

Any publicació:

2020

Número de revista: